• Post-Traumatic Stress Disorder (commonly referred to by its acronym, PTSD) is a severe anxiety disorder that can develop after exposure to any event which results in psychological trauma. This event may involve the threat of death to oneself or to someone else, or to one's own or someone else's physical, sexual, or psychological integrity, overwhelming the individual's psychological defenses.

    PTSD is a less frequent and more enduring consequence of psychological trauma than the more frequently seen acute stress response. PTSD has also been recognized in the past as railway spine, stress syndrome, shell shock, battle fatigue, traumatic war neurosis, or post-traumatic stress syndrome.

    Diagnostic symptoms include re-experiencing original trauma(s), by means of flashbacks or nightmares; avoidance of stimuli associated with the trauma; and increased arousal, such as difficulty falling or staying asleep, anger, and hyper vigilance. Formal diagnostic criteria (both DSM-IV and ICD-9) require that the symptoms last more than one month and cause significant impairment in social, occupational, or other important areas of functioning (e.g. problems with work and/or relationships).

    A study conducted at the Universitá di Firenze in Italy finds there is positive indications cannabis could help treat PTSD: "Consolidation refers to item stabilization in long-term memory. Retrieval renders a consolidated memory sensitive, and a "reconsolidation" process has been hypothesized to keep the original memory persistent. Some authors could not detect this phenomenon. Here we show that retrieved contextual fear memory is vulnerable to amnesic treatments and that the amygdala is critically involved. Cholinergic and histaminergic systems seem to modulate only consolidation, whereas cannabinoids are involved in both consolidation and reactivation. The liability of retrieved memory affords opportunities to treat disorders such as phobias, post-traumatic stress, or chronic pain, and these results help searching for appropriate therapeutic targets."

  • Category
    Critical Ailments
  • Created
    Thursday, 30 November 2017
  • Group admin

Cannabis Science Economic Development Program

Cannabis Science Economic Development Plan

Cannabis Science Share Structure Updates

CBIS Share Structure Updates

Cannabis Science Updates

CBIS Updates

Transfer Agent

Securities Transfer Corp.

STC is regulated by the Securities and Exchange Commission

2901 N Dallas Parkway
Suite 380
Plano, Texas 75093
(469) 633-0101

Become an iCannabinoid Ambassador


Observational Studies


Activity Stream

Raymond C. Dabney Raymond C. Dabney This is exactly why I wrote this statement.

We will probably put out the July 1, 2020 Edition after the Fourth...
Show more

Dale Leister Not sure how to see your post, the last thing I saw from you was two months ago. I’m not trying to push or be sarcastic I’m just trying to find out... Show more yesterday
Raymond C. Dabney I think if you click my profile name or anyone's name in the system you can see all the posts they've ever written, that is not deleted. It is... Show more Loading content, please wait. 14 hours 23 minutes ago
Tim W. H. Raymond, one of the strong points of our company website is the shareholder 'free speech' aspect.
Unfortunately, this day and time internet dialog...
Show more
10 hours 14 minutes ago



Sorry, we currently have no events.
View All Events